86 related articles for article (PubMed ID: 2450201)
1. New 1,4-dihydropyridines with vasoconstrictor action through activation of Ca++-channels.
Takenaka T; Inagaki O; Terai M; Asano M; Kubo K
J Pharmacol Exp Ther; 1988 Feb; 244(2):699-708. PubMed ID: 2450201
[TBL] [Abstract][Full Text] [Related]
2. Vascular and cardiac effects of a new dihydropyridine derivative, YC-170: a comparison with Bay K 8644.
Hattori Y; Nakaya H; Tohse N; Kanno M
J Pharmacol Exp Ther; 1986 Aug; 238(2):670-8. PubMed ID: 2426442
[TBL] [Abstract][Full Text] [Related]
3. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
[TBL] [Abstract][Full Text] [Related]
4. Effects of nicardipine, a new dihydropyridine vasodilator, on coronary circulation and ischemia-induced conduction delay in dogs.
Nakaya H; Kanno M
Arzneimittelforschung; 1982; 32(6):626-9. PubMed ID: 7202368
[TBL] [Abstract][Full Text] [Related]
5. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
6. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
[TBL] [Abstract][Full Text] [Related]
7. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of diltiazem, verapamil, nifedipine, and nicardipine on sympathetic tachycardia in decentralized hearts of anesthetized dogs.
Satoh E; Mukaiyama O; Kimura T; Satoh S
J Cardiovasc Pharmacol; 1990 Oct; 16(4):661-6. PubMed ID: 1706810
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
Yamaura T; Kase N; Kita H; Uematsu T
Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
[TBL] [Abstract][Full Text] [Related]
10. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
[TBL] [Abstract][Full Text] [Related]
11. Vasorelaxing and receptor binding properties of NZ-105, a novel dihydropyridine derivative, in isolated rabbit aorta.
Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
Arch Int Pharmacodyn Ther; 1991; 312():86-103. PubMed ID: 1663336
[TBL] [Abstract][Full Text] [Related]
12. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
13. Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants.
Schramm M; Thomas G; Towart R; Franckowiak G
Arzneimittelforschung; 1983; 33(9):1268-72. PubMed ID: 6196037
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats.
Karasawa A; Kubo K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological studies of a newly synthetized 1,4-dihydropyridine derivative, 2,6-dimethyl-3,5-dimethoxycarbonyl-4- (o-difluoromethoxyphenyl)-1,4-dihydropyridine (PP-1466).
Toribatake T; Fujii K; Kobayashi M; Okumura M; Aikawa K
Arzneimittelforschung; 1985; 35(4):680-6. PubMed ID: 4015734
[TBL] [Abstract][Full Text] [Related]
16. Calcium entry blockade by nitrendipine and alpha adrenergic responsiveness in vivo: comparison of systemic vs. local effects.
Pedrinelli R; Tarazi RC
J Pharmacol Exp Ther; 1985 Jun; 233(3):643-9. PubMed ID: 2861275
[TBL] [Abstract][Full Text] [Related]
17. [Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine].
Pruneau D; Roy F; Brown NL
Therapie; 1989; 44(3):203-8. PubMed ID: 2781506
[TBL] [Abstract][Full Text] [Related]
18. In vitro comparative studies of the calcium-entry activators YC-170, CGP 28392, and BAY K 8644.
Rogg H; Criscione L; Truog A; Meier M
J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S31-7. PubMed ID: 2414592
[TBL] [Abstract][Full Text] [Related]
19. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.
Sybertz EJ; Watkins RW; Baum T; Pula K; Rivelli M
J Pharmacol Exp Ther; 1985 Jan; 232(1):156-62. PubMed ID: 3917504
[TBL] [Abstract][Full Text] [Related]
20. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding.
Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H
Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
